About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [826 citations: 1–100 of 786 articles]

Articles published in Prostate Cancer have been cited 826 times. The following is a list of the 786 articles that have cited the articles published in Prostate Cancer.

  • Steven Kammann, Christine Menias, Amy Hara, Mariam Moshiri, Cary Siegel, Bashar Safar, Steven Brandes, Akram Shaaban, and Kumar Sandrasegaran, “Genital and reproductive organ complications of Crohn disease: technical considerations as it relates to perianal disease, imaging features, and implications on management,” Abdominal Radiology, 2017. View at Publisher · View at Google Scholar
  • Motolani E. Ogunsanya, Carolyn M. Brown, Folakemi T. Odedina, Jamie C. Barner, Taiwo B. Adedipe, and Brittany Corbell, “Knowledge of Prostate Cancer and Screening Among Young Multiethnic Black Men,” American Journal of Men's Health, pp. 155798831668949, 2017. View at Publisher · View at Google Scholar
  • Colin P. Bergstrom, Brian Ruffell, Christine M.T. Ho, Celestia S. Higano, William J. Ellis, Mark Garzotto, Tomasz M. Beer, and Julie N. Graff, “Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer,” Anti-Cancer Drugs, vol. 28, no. 1, pp. 120–126, 2017. View at Publisher · View at Google Scholar
  • N. P. Akentieva, and S. S. Shushanov, “Inhibition of cancer cell invasiveness by synthetic peptides GEGEEGEE and DFGEEAEE,” Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, vol. 11, no. 1, pp. 24–34, 2017. View at Publisher · View at Google Scholar
  • Pu Li, Chenkui Miao, Chao Liang, Pengfei Shao, Zengjun Wang, and Jie Li, “Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion via AKT/mTOR Signal Pathway,” BioMed Research International, vol. 2017, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Jieke Yan, Yuzhen Wang, Yuxiu Jia, Shuangde Liu, Chuan Tian, Wengu Pan, Xiaoli Liu, and Hongwei Wang, “Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer,” Biomedicine & Pharmacotherapy, vol. 88, pp. 374–383, 2017. View at Publisher · View at Google Scholar
  • P. Blanchard, C. Ménard, and S.J. Frank, “Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow,” Brachytherapy, 2017. View at Publisher · View at Google Scholar
  • Wan Song, Joon Hyung Park, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, and Han Yong Choi, “Comparison of Oncologic Outcomes and Complications by Surgical Approach to Radical Prostatectomy: Special Focus on Perineal Approach,” Clinical Genitourinary Cancer, 2017. View at Publisher · View at Google Scholar
  • Stephen J Foulkes, Robin M Daly, and Steve F Fraser, “The clinical importance of quantifying body fat distribution during androgen deprivation therapy for prostate cancer,” Endocrine-Related Cancer, vol. 24, no. 3, pp. R35–R48, 2017. View at Publisher · View at Google Scholar
  • Mateja Kralj Juric, Maxim Shevtsov, Petra Mozes, Justyna Ogonek, Rachel E. Crossland, Anne M. Dickinson, Hildegard T. Greinix, Ernst Holler, Eva M. Weissinger, and Gabriele Multhoff, “B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation,” Frontiers in Immunology, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Zubing Mei, Mining Liang, Lezhi Li, Yi Zhang, Qingming Wang, and Wei Yang, “Effects of statins on cancer mortality and progression: A systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals,” International Journal of Cancer, vol. 140, no. 5, pp. 1068–1081, 2017. View at Publisher · View at Google Scholar
  • Megan S. Farris, Karen A. Kopciuk, Kerry S. Courneya, S. Elizabeth McGregor, Qinggang Wang, and Christine M. Friedenreich, “Identification and prediction of health-related quality of life trajectories after a prostate cancer diagnosis,” International Journal of Cancer, 2017. View at Publisher · View at Google Scholar
  • Gustavo Arruda Viani, and Aline Sakamoto, “Outpatient application of formalin for chronic rectal bleeding after prostate irradiation: a quasi-experimental study,” International Journal of Colorectal Disease, 2017. View at Publisher · View at Google Scholar
  • Yoshiyasu Amiya, Yasutaka Yamada, Masahiro Sugiura, Makoto Sasaki, Takayuki Shima, Noriyuki Suzuki, Hiroomi Nakatsu, Shino Murakami, and Jun Shimazaki, “Treatment of locally advanced prostate cancer (Stage T3),” Japanese Journal of Clinical Oncology, 2017. View at Publisher · View at Google Scholar
  • Ewan K. Cobran, Jori N. Hall, and William D. Aiken, “African-American and Caribbean-Born Men’s Perceptions of Prostate Cancer Fear and Facilitators for Screening Behavior: a Pilot Study,” Journal of Cancer Education, 2017. View at Publisher · View at Google Scholar
  • Lipsa Das, Todd A. Anderson, Jaime M.C. Gard, Isis C. Sroka, Stephanie R. Strautman, Raymond B. Nagle, Colm Morrissey, Beatrice S. Knudsen, and Anne E. Cress, “Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells,” Journal of Cellular Biochemistry, 2017. View at Publisher · View at Google Scholar
  • Okon Ekwere Essien, Iya Eze Bassey, Rebecca Mtaku Gali, Alphonsus Ekpe Udoh, Uwem Okon Akpan, and Enakirerhi E. Glen, “Cardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy?,” Journal of Global Oncology, vol. 3, no. 1, pp. 7–14, 2017. View at Publisher · View at Google Scholar
  • Yuma Waseda, Soichiro Yoshida, Taro Takahara, Thomas Christian Kwee, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, and Yasuhisa Fujii, “Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer,” Journal of Magnetic Resonance Imaging, 2017. View at Publisher · View at Google Scholar
  • Sergio Faria, Russel Ruo, Fabio Cury, Marie Duclos, and Luis Souhami, “Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiation therapy,” Practical Radiation Oncology, 2017. View at Publisher · View at Google Scholar
  • S A Patel, M-H Chen, M Loffredo, A Renshaw, P W Kantoff, and A V D'Amico, “The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer,” Prostate Cancer and Prostatic Diseases, 2017. View at Publisher · View at Google Scholar
  • Mia Møller, Siri Hundtofte Strand, Kamilla Mundbjerg, Gangning Liang, Inderbir Gill, Christa Haldrup, Michael Borre, Søren Høyer, Torben Falck Ørntoft, and Karina Dalsgaard Sørensen, “Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients,” Scientific Reports, vol. 7, pp. 40636, 2017. View at Publisher · View at Google Scholar
  • Rosalyn W. Stewart, Sergio Lizama, Kimberly Peairs, Heather F. Sateia, and Youngjee Choi, “Screening for Prostate Cancer,” Seminars in Oncology, 2017. View at Publisher · View at Google Scholar
  • Lei Ge, Yang Yang, Yifeng Sun, Wen Xu, Daru Lu, and Bo Su, “ P73 G4C14-to-A4T14 polymorphism is associated with survival in advanced non-small cell lung cancer patients ,” Thoracic Cancer, 2017. View at Publisher · View at Google Scholar
  • Sundhar Ramalingam, Michael S. Humeniuk, Rachel Hu, Julia Rasmussen, Patrick Healy, Yuan Wu, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, and Tian Zhang, “Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate–resistant prostate cancer,” Urologic Oncology: Seminars and Original Investigations, 2017. View at Publisher · View at Google Scholar
  • N. Urban, and F. Beyersdorf, “Hypothermie und ihr Einfluss auf das Tumorwachstum,” Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2017. View at Publisher · View at Google Scholar
  • Venkata S. Katabathina, Raghu Vikram, Adeniran Olaoya, Raj Mohan Paspulati, Marlo M. Nicolas, Priya Rao, Atif Zaheer, and Srinivasa R. Prasad, “Neuroendocrine neoplasms of the genitourinary tract in adults: cross-sectional imaging spectrum,” Abdominal Radiology, 2016. View at Publisher · View at Google Scholar
  • H. Xu, P.D. Bai, M.B. Hu, S.H. Mao, W.H. Zhu, J.M. Hu, S.H. Liu, T. Yang, J.Y. Hou, Y. Hu, Q. Ding, and H.W. Jiang, “Infragradación de la biopsia de próstata respecto a la pieza de prostatectomía la población china: nomogramas actualizados,” Actas Urológicas Españolas, 2016. View at Publisher · View at Google Scholar
  • A. Guijarro, L. Reguero, V. Hernández, J.M. de la Morena, E. De la Peña, B. López, B. Fernández, C. Parrilla, E. Pérez-Fernández, I. Alemany, and C. Llorente, “Diagnostic yield and complications of extended lymphadenectomy versus limited lymphadenectomy combined with radical prostatectomy,” Actas Urológicas Españolas (English Edition), 2016. View at Publisher · View at Google Scholar
  • Ayobami Ajayi, Wei-Ting Hwang, Neha Vapiwala, Mark Rosen, Christina H. Chapman, Stefan Both, Meera Shah, Xingmei Wang, Atu Agawu, Peter Gabriel, John Christodouleas, Zelig Tochner, and Curtiland Deville, “Disparities in Staging Prostate Magnetic Resonance Imaging Utilization for Non-Metastatic Prostate Cancer Patients Undergoing Definitive Radiotherapy,” Advances in Radiation Oncology, 2016. View at Publisher · View at Google Scholar
  • Axel S. Merseburger, and Marie C. Hupe, “An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer,” Advances in Therapy, 2016. View at Publisher · View at Google Scholar
  • Aifen Li, Jieyu Xing, Li Li, Changhua Zhou, Bin Dong, Ping He, Qing Li, and Zhong Wang, “A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells,” AMB Express, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yu-Dong Zhang, Chen-Jiang Wu, Mei-Ling Bao, Hai Li, Xu Yan, Xi-Sheng Liu, and Hai-Bin Shi, “New RESOLVE-Based Diffusional Kurtosis Imaging in MRI-Visible Prostate Cancer: Effect of Reduced b Value on Image Quality and Diagnostic Effectiveness,” American Journal of Roentgenology, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Minyong Kang, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Sang Eun Lee, and Seok-Soo Byun, “Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy,” Annals of Surgical Oncology, vol. 23, no. 8, pp. 2699–2706, 2016. View at Publisher · View at Google Scholar
  • Francisco D.C. Guerra Liberal, Adriana Alexandre S. Tavares, and João Manuel R.S. Tavares, “Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153,” Applied Radiation and Isotopes, 2016. View at Publisher · View at Google Scholar
  • Yuejiao Huang, Chun Cheng, Chong Zhang, Yonghui Zhang, Miaomiao Chen, Douglas W. Strand, and Ming Jiang, “Advances in prostate cancer research models: from transgenic mice to tumor xenografting models,” Asian Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • Jin Xu, and Yun Qiu, “Role of androgen receptor splice variants in prostate cancer metastasis,” Asian Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • William L. Harryman, James P. Hinton, Cynthia P. Rubenstein, Parminder Singh, Raymond B. Nagle, Sarah J. Parker, Beatrice S. Knudsen, and Anne E. Cress, “The Cohesive Metastasis Phenotype in Human Prostate Cancer,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2016. View at Publisher · View at Google Scholar
  • Lawrence G. Lum, Archana Thakur, Sri Vidya Kondadasula, Zaid Al-Kadhimi, Abhinav Deol, Elyse N. Tomaszewski, Hiroshi Yano, Dana L. Schalk, Lois Ayash, Jeffrey A. Zonder, Joseph P. Uberti, Muneer H. Abidi, and Voravit Ratanatharathorn, “Targeting Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity,” Biology of Blood and Marrow Transplantation, 2016. View at Publisher · View at Google Scholar
  • Ying Hao, Aidan B. Zerdoum, Alexander J. Stuffer, Ayyappan K Rajasekaran, and Xinqiao Jia, “Biomimetic Hydrogels Incorporating Polymeric Cell-Adhesive Peptide to Promote the 3D Assembly of Tumoroids,” Biomacromolecules, 2016. View at Publisher · View at Google Scholar
  • Ben G. L. Vanneste, Evert J. Van Limbergen, Emile N. van Lin, Joep G. H. van Roermund, and Philippe Lambin, “Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?,” BioMed Research International, vol. 2016, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Domenica Rea, Vitale del Vecchio, Giuseppe Palma, Antonio Barbieri, Michela Falco, Antonio Luciano, Davide De Biase, Sisto Perdonà, Gaetano Facchini, and Claudio Arra, “Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX,” BioMed Research International, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Ruifeng Fan, Haidong Yao, Xia Zhao, Changyu Cao, Tianshu Yang, Yilin Luan, Ziwei Zhang, and Shiwen Xu, “Gene expression of selenoproteins can be regulated by selenoprotein K silencing in chicken myoblasts,” BioMetals, 2016. View at Publisher · View at Google Scholar
  • Tine M. Storebjerg, Søren Høyer, Pia Kirkegaard, Flemming Bro, Torben F. Ørntoft, Michael Borre, and Karina D. Sørensen, “ Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness ,” BJU International, 2016. View at Publisher · View at Google Scholar
  • Kasper D. Berg, Frederik B. Thomsen, Camilla Nerstrøm, Martin A. Røder, Peter Iversen, Birgitte G. Toft, Ben Vainer, and Klaus Brasso, “The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis,” BJU International, vol. 117, no. 6, pp. 883–889, 2016. View at Publisher · View at Google Scholar
  • Jin Tae Kwak, Stephen M. Hewitt, André Alexander Kajdacsy-Balla, Saurabh Sinha, and Rohit Bhargava, “Automated prostate tissue referencing for cancer detection and diagnosis,” BMC Bioinformatics, vol. 17, no. 1, 2016. View at Publisher · View at Google Scholar
  • Ping Jiang, Christof van der Horst, Bernhard Kimmig, Fabian Zinsser, Bjoern Poppe, Ulf Luetzen, Klaus-Peter Juenemann, Juergen Dunst, and Frank-André Siebert, “Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome,” Brachytherapy, 2016. View at Publisher · View at Google Scholar
  • V. Atallah, N. Leduc, M. Creoff, P. Sargos, T. Taouil, P. Escarmant, and V. Vinh-Hung, “Curative brachytherapy for prostate cancer in African-Caribbean patients: A retrospective analysis of 370 consecutive cases,” Brachytherapy, 2016. View at Publisher · View at Google Scholar
  • Payal D. Soni, Alejandro Berlin, Aradhana M. Venkatesan, and Patrick W. McLaughlin, “MRI-guided functional anatomy approach to prostate brachytherapy,” Brachytherapy, 2016. View at Publisher · View at Google Scholar
  • Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H. Partridge, and Judy E. Garber, “Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care,” Breast Cancer Research and Treatment, 2016. View at Publisher · View at Google Scholar
  • Kristina Stuopelyte, Kristina Daniunaite, Arnas Bakavicius, Juozas R Lazutka, Feliksas Jankevicius, and Sonata Jarmalaite, “The utility of urine-circulating miRNAs for detection of prostate cancer,” British Journal of Cancer, 2016. View at Publisher · View at Google Scholar
  • Carol E. DeSantis, Rebecca L. Siegel, Ann Goding Sauer, Kimberly D. Miller, Stacey A. Fedewa, Kassandra I. Alcaraz, and Ahmedin Jemal, “Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities,” CA: A Cancer Journal for Clinicians, 2016. View at Publisher · View at Google Scholar
  • Ilinca Georgescu, Robert J. Gooding, R. Christopher Doiron, Andrew Day, Shamini Selvarajah, Chris Davidson, David M. Berman, and Paul C. Park, “Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes,” Cancer & Metabolism, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar
  • Lei Wang, Hong Ma, Lixia Zhu, Liping Ma, Lanting Cao, Hui Wei, and Jumei Xu, “Screening for the optimal gene and functional gene sets related to breast cancer using differential co-expression and differential expression analysis,” Cancer Biomarkers, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Lindsey A. Torre, Rebecca L. Siegel, Elizabeth M. Ward, and Ahmedin Jemal, “Global Cancer Incidence and Mortality Rates and Trends-An Update,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 1, pp. 16–27, 2016. View at Publisher · View at Google Scholar
  • Richard M. Hoffman, Angela L. W. Meisner, Wadih Arap, Marc Barry, Satyan K. Shah, Steven B. Zeliadt, and Charles L. Wiggins, “Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 2, pp. 259–263, 2016. View at Publisher · View at Google Scholar
  • Emma H. Allott, Lauren E. Howard, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, and Stephen J. Freedland, “Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database,” Cancer Epidemiology Biomarkers & Prevention, vol. 25, no. 3, pp. 547–554, 2016. View at Publisher · View at Google Scholar
  • Ailin Zhang, Jiawei Zhang, Arja Kaipainen, Jared M. Lucas, and Hong Yang, “Long non-coding RNA: A newly deciphered “code” in prostate cancer,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Eileen Brantley, Mariana A. Callero, Damian E. Berardi, Petreena Campbell, Leah Rowland, Dain Zylstra, Louisa Amis, Michael Yee, Marina Simian, Laura Todaro, Andrea Loaiza-Perez, and Ubaldo Soto, “AhR ligand aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Guozhe Xian, Juan Zhao, Chengkun Qin, Zhenhai Zhang, Yanliang Lin, and Zhongxue Su, “Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis,” Cancer Letters, 2016. View at Publisher · View at Google Scholar
  • Alexandru Mihai Nicolae, Niranjan Venugopal, and Ananth Ravi, “Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers,” Cancer Nanotechnology, vol. 7, no. 1, 2016. View at Publisher · View at Google Scholar
  • Claudia Peitzsch, Monica Cojoc, Linda Hein, Ina Kurth, Katrin Maebert, Franziska Trautmann, Barbara Klink, Evelin Schroeck, Manfred P. Wirth, Mechthild Krause, Eduard A. Stakhovsky, GennadyD. Telegeev, Vladimir Novotny, Marieta Toma, Michael Muders, Gustavo B. Baretton, Fiona M. Frame, Norman J. Maitland, Michael Baumann, and Anna Dubrovska, “An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells,” Cancer Research, vol. 76, no. 9, pp. 2637–2651, 2016. View at Publisher · View at Google Scholar
  • Imran Ali, Bettina Julin, Anders Glynn, Johan Högberg, Marika Berglund, Jan-Erik Johansson, Swen-Olof Andersson, Ove Andrén, Edward Giovannucci, Alicja Wolk, Ulla Stenius, and Agneta Åkesson, “Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies,” Carcinogenesis, pp. bgw105, 2016. View at Publisher · View at Google Scholar
  • Antonio Balestrieri, Elena Magnani, and Fiorella Nuzzo, “Unusual Cushing’s Syndrome and Hypercalcitoninaemia due to a Small Cell Prostate Carcinoma,” Case Reports in Endocrinology, vol. 2016, pp. 1–5, 2016. View at Publisher · View at Google Scholar
  • A J Browne, A Göbel, S Thiele, L C Hofbauer, M Rauner, and T D Rachner, “p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells,” Cell Death and Disease, vol. 7, no. 2, pp. e2119, 2016. View at Publisher · View at Google Scholar
  • Wan Low, and Nahrizul Kadri, “Computational Analysis of Enhanced Circulating Tumour Cell (CTC) Separation in a Microfluidic System with an Integrated Dielectrophoretic-Magnetophorectic (DEP-MAP) Technique,” Chemosensors, vol. 4, no. 3, pp. 14, 2016. View at Publisher · View at Google Scholar
  • Christina Bluemel, and Ken Herrmann, “New technologies in radioguided surgery in complex anatomic areas,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • Sergi Vidal-Sicart, and Renato A. Valdés Olmos, “Synergism of SPECT/CT and portable gamma cameras for intraoperative sentinel lymph node biopsy in melanoma, breast cancer, and other malignancies,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • M. R. Grootendorst, M. Cariati, A. Kothari, D. S. Tuch, and A. Purushotham, “Cerenkov luminescence imaging (CLI) for image-guided cancer surgery,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • O. R. Brouwer, H. G. van der Poel, R. F. Bevers, E. J. van Gennep, and S. Horenblas, “Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?,” Clinical and Translational Imaging, 2016. View at Publisher · View at Google Scholar
  • Renata Zelic, Valentina Fiano, Daniela Zugna, Chiara Grasso, Luisa Delsedime, Lorenzo Daniele, Diego Galliano, Andreas Pettersson, Anna Gillio-Tos, Franco Merletti, and Lorenzo Richiardi, “Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebi,” Clinical Cancer Research, vol. 22, no. 4, pp. 984–992, 2016. View at Publisher · View at Google Scholar
  • Adam Kowalewski, Łukasz Szylberg, Anna Skórczewska, and Andrzej Marszałek, “Diagnostic difficulties with atrophy, atypical adenomatous hyperplasia (AAH) and atypical small acinar proliferation (ASAP). A Systematic Review of Current Literature,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • John M. Watkins, Darrion L. Mitchell, J. Kyle Russo, Sarah L. Mott, Chad R. Tracy, Mark C. Smith, and John M. Buatti, “Gleason Score ≤ 6 Prostate Cancer at Radical Prostatectomy: Does a High-Risk Setting Truly Exist? A Recursive Partitioning Analysis,” Clinical Genitourinary Cancer, 2016. View at Publisher · View at Google Scholar
  • Negar Pouyanfar, Ahmad Monabbati, Alireza Amin Sharifi, and Mehdi Dianatpour, “Expression Levels of MMP9 and PIWIL2 in Prostate Cancer: a Case-Control Study,” Clinical Laboratory, vol. 62, no. 4, pp. 651–657, 2016. View at Publisher · View at Google Scholar
  • G. Giuliani, F. Guerra, D. Coletta, M. La Torre, G. Franco, C. Leonardo, A. Infantino, and F. La Torre, “Repair of transperineal recto-urethral fistula using a fibrin sealant haemostatic patch,” Colorectal Disease, vol. 18, no. 11, pp. O432–O435, 2016. View at Publisher · View at Google Scholar
  • Jean Piechowski, “Trophoblastic-like transdifferentiation: A key to oncogenesis,” Critical Reviews in Oncology/Hematology, 2016. View at Publisher · View at Google Scholar
  • Maria J. Alvarez-Cubero, Fernando Vazquez-Alonso, Ignacio Puche-Sanz, F. Gabriel Ortega, M. Martin-Prieto, Jose L. Garcia-Puche, Manrique Pascual-Geler, Jose A. Lorente, Jose M. Cozar-Olmo, and Maria J. Serrano, “Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications,” Current Drug Targets, vol. 17, no. 6, pp. 693–701, 2016. View at Publisher · View at Google Scholar
  • Maria Raffaella Ambrosio, Luigi Pirtoli, and Maria Teresa del Vecchio, “Emerging Targets for Prostate Adenocarcinoma Therapy: How Molecular Biology May Drive Towards a More Tailored Approach?,” Current Drug Targets, vol. 17, no. 3, pp. 266–275, 2016. View at Publisher · View at Google Scholar
  • Mandi M. Hopkins, and Kathryn E. Meier, “Omega-3 Fatty Acids and Their Impact on Prostate Cancer Risk,” Current Nutrition Reports, 2016. View at Publisher · View at Google Scholar
  • Eugene A Zhukovsky, Richard J Morse, and Marcela V Maus, “Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection,” Current Opinion in Immunology, vol. 40, pp. 24–35, 2016. View at Publisher · View at Google Scholar
  • Lisa M. Cordes, James L. Gulley, and Ravi A. Madan, “The evolving role of immunotherapy in prostate cancer,” Current Opinion in Oncology, vol. 28, no. 3, pp. 232–240, 2016. View at Publisher · View at Google Scholar
  • Manish K. Thakur, and Ulka Vaishampayan, “Multifaceted and personalized therapy of advanced prostate cancer,” Current Opinion in Oncology, vol. 28, no. 3, pp. 222–231, 2016. View at Publisher · View at Google Scholar
  • Marlon Perera, Todd Manning, Antonio Finelli, and Nathan Lawrentschuk, “Management of men with previous negative prostate biopsy,” Current Opinion in Urology, vol. 26, no. 5, pp. 481–487, 2016. View at Publisher · View at Google Scholar
  • Christina J. Turner, and Claire M. Edwards, “The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease,” Current Osteoporosis Reports, 2016. View at Publisher · View at Google Scholar
  • Ester Fernandez-Salas, Shaomeng Wang, and Arul M Chinnaiyan, “Role of BET proteins in castration-resistant prostate cancer,” Drug Discovery Today: Technologies, 2016. View at Publisher · View at Google Scholar
  • Ayorinde Adehin, Oluseye Oladotun Bolaji, and Martin A. Kennedy, “Polymorphisms in CYP2C8 and CYP3A5 genes in the Nigerian population,” Drug Metabolism and Pharmacokinetics, 2016. View at Publisher · View at Google Scholar
  • Skerdi Haviari, Pierre Cassier, Cédric Dananché, Monique Hulin, Olivier Dauwalder, Olivier Rouvière, Xavier Bertrand, Michel Perraud, Thomas Bénet, and Philippe Vanhems, “ Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014 ,” Emerging Infectious Diseases, vol. 22, no. 8, 2016. View at Publisher · View at Google Scholar
  • Minzan Zuo, Xi Xu, Zhouling Xie, Raoling Ge, Ziyu Zhang, Zhiyu Li, and Jinlei Bian, “Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer,” European Journal of Medicinal Chemistry, 2016. View at Publisher · View at Google Scholar
  • Luigia Florimonte, Luca Dellavedova, and Lorenzo Stefano Maffioli, “Radium-223 dichloride in clinical practice: a review,” European Journal of Nuclear Medicine and Molecular Imaging, 2016. View at Publisher · View at Google Scholar
  • Serena Pullini, Marco Andrea Signor, Martina Pancot, Chiara Zuiani, Massimo Bazzocchi, Sandro Fongione, and Rossano Girometti, “Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy,” European Journal of Radiology, vol. 85, no. 4, pp. 764–770, 2016. View at Publisher · View at Google Scholar
  • Giulio Nicita, Donata Villari, Simone Caroassai Grisanti, Michele Marzocco, Vincenzo Li Marzi, and Alberto Martini, “Minimally Invasive Transanal Repair of Rectourethral Fistulas,” European Urology, 2016. View at Publisher · View at Google Scholar
  • Tong Song, Xia Tian, Fan Kai, Jiang Ke, Zhai Wei, Li Jing-Song, Wang Jian-Jun, and Wang Si-Hua, “14-3-3ζ promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)/NF-κB signaling,” Experimental Cell Research, 2016. View at Publisher · View at Google Scholar
  • Archana Thakur, and Lawrence G. Lum, ““NextGen” Biologics: Bispecific Antibodies and Emerging Clinical Results,” Expert Opinion on Biological Therapy, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Athanasios Dellis, and Athanasios G. Papatsoris, “Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer,” Expert Opinion on Investigational Drugs, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Sherry Zhao, Alfredo I. Urdaneta, and Mitchell S. Anscher, “The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer,” Expert Review of Anticancer Therapy, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Fable Zustovich, and Davide Pastorelli, “Therapeutic management of bone metastasis in prostate cancer: an update,” Expert Review of Anticancer Therapy, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Lev M. Berstein, “Insulinemia, heterogeneity of obesity and the risk of different types of endometrial cancer: existing evidence,” Expert Review of Endocrinology & Metabolism, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Maria Russo, Gian Luigi Russo, Maria Daglia, Pandima Devi Kasi, Sakthivel Ravi, Seyed Fazel Nabavi, and Seyed Mohammad Nabavi, “Understanding genistein in cancer: The “good” and the “bad” effects: A review,” Food Chemistry, vol. 196, pp. 589–600, 2016. View at Publisher · View at Google Scholar
  • Ken Batai, Adam B. Murphy, Larisa Nonn, and Rick A. Kittles, “Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans,” Frontiers In Immunology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Maria Ferraiuolo, Silvia Di Agostino, Giovanni Blandino, and Sabrina Strano, “Oncogenic Intra-p53 Family Member Interactions in Human Cancers,” Frontiers in Oncology, vol. 6, 2016. View at Publisher · View at Google Scholar
  • Hans-Theo Schon, and Ralf Weiskirchen, “Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury,” Frontiers in Pharmacology, vol. 07, 2016. View at Publisher · View at Google Scholar